| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-12 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-06 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-05 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.13 | 8e-05 |